This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Enrollment
70
Bilateral middle meningeal artery embolization using TRUFILL n-BCA liquid embolic system
Hartford Hospital
Hartford, Connecticut, United States
NOT_YET_RECRUITINGMount Sinai
New York, New York, United States
RECRUITINGStony Brook University Medical Center
Stony Brook, New York, United States
Change from baseline, in number of migraine days
Time frame: over 28 days
Change from baseline in migraine days frequency
Time frame: 3 months and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
RECRUITINGSemmes Murphey Foundation
Memphis, Tennessee, United States
RECRUITINGWest Virginia University
Morgantown, West Virginia, United States
RECRUITING